Danielruben Miranda
Psychiatric/Mental Health · Pomona, CANPI 1619629367
Payments from drug & device makers
Across 181 payments — averaging $29.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$887
- Vanda Pharmaceuticals Inc.$795
- Teva Pharmaceuticals USA, Inc.$700
- E.r. Squibb & Sons, L.L.C.$616
- Alkermes, Inc.$609
- Indivior Inc.$430
- plus $1K from 11 others
What the payments were for
- Food & beverage$5,412100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 22 | $887 |
| Vanda Pharmaceuticals Inc. | 19 | $795 |
| Teva Pharmaceuticals USA, Inc. | 28 | $700 |
| E.r. Squibb & Sons, L.L.C. | 21 | $616 |
| Alkermes, Inc. | 17 | $609 |
| Indivior Inc. | 17 | $430 |
| Neurocrine Biosciences, Inc. | 15 | $346 |
| Otsuka America Pharmaceutical, Inc. | 16 | $285 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $202 |
| AbbVie | 7 | $181 |
| Idorsia Pharmaceuticals US Inc | 1 | $121 |
| Noven Therapeutics, LLC | 3 | $66 |
| Tempus AI, Inc | 2 | $58 |
| Braeburn Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| Gilead | 1 | $23 |
| Luye Pharma (USA) Ltd. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,000
- INVEGA SUSTENNA$300
- COBENFY$248
- Fanapt$225
- INVEGA TRINZA$150
- QUVIVIQ$121
How this compares
$5,412 in reported general payments places this provider in the 90th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olanzapine | 18 | $403 |
| Aripiprazole | 11 | $271 |
| Hydroxyzine Pamoate | 16 | $78 |
| Escitalopram Oxalate | 20 | $61 |
| Fluoxetine Hcl | 16 | $53 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Pomona
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- David OhIrvine$72K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
- Sarah KoLos Angeles$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.